Global ETD Search

Search theses and dissertations gathered from participating repositories worldwide. Every result links back to the library that holds it. No account is needed.

Results

Showing 1 to 11 of 11 for “"Biosimilarity"”.

  1. Biosimilarity assessment of biopharmaceuticals for quality control

    … from different manufacturers to demonstrate biosimilarity is extremely challenging. Here, we refer to this type of comparability as an ‘external’ comparison. Since biosimilars differ from generic small molecules, the demonstration of biosimilarity requires extensive analytical tools. In the …

    fu-berlin Repository record for Biosimilarity assessment of biopharmaceuticals for quality control (opens in a new tab)

  2. Adaptive methodologies in multi-arm dose response and biosimilarity clinical trials

    … extended to binary and survival endpoints. In a biosimilarity trial, we are interested in establishing evidence of comparable efficacy between a follow-on biological product and a reference innovator product. So far, no standard method for biosimilarity has been endorsed by regulatory agency. We …

    bu Repository record for Adaptive methodologies in multi-arm dose response and biosimilarity clinical trials (opens in a new tab)

  3. Analysis of Two-Stage Seamless Adaptive Design in Clinical Development and Its Applications

    … of this thesis addresses efficient evidence for biosimilarity assessment. An innovative Biosimilarity Index (BI) is introduced to formalize decision making for biosimilarity when pharmacokinetic similarity provides the primary evidentiary basis, with performance compared against the conventional …

    duke Repository record for Analysis of Two-Stage Seamless Adaptive Design in Clinical Development and Its Applications (opens in a new tab)

  4. Structural Mass Spectrometry Analysis of RNA Chaperones and Protein Therapeutics

    … structural MS techniques were used to assess the biosimilarity between a biological drug, Avastin, and its biosimilar in pre-clinical development. Work was done to test the structural similarity between the two drugs and the batch-to-batch variability of the biosimilar. Structural MS proved to be …

    york Repository record for Structural Mass Spectrometry Analysis of RNA Chaperones and Protein Therapeutics (opens in a new tab)

  5. Engineering Chinese Hamster Ovary cell recombinant protein glycosylation

    … a spectrum of analytical methods to demonstrate biosimilarity, including high-resolution mass spectrometry and biochemical and cell-based assays. In fed-batch cultures, two CHO cell clones were identified that maintained stable production while matching the glycosylation profile and function of …

    ubc Repository record for Engineering Chinese Hamster Ovary cell recombinant protein glycosylation (opens in a new tab) Download PDF for Engineering Chinese Hamster Ovary cell recombinant protein glycosylation (opens in a new tab)

  6. Novel Bayesian Adaptive Clinical Trial Designs In Early Phases

    … Guidelines for statistical methods to establish biosimilarity remain nonspecific because of the newness of biosimilars. It is therefore of high urgency to develop appropriate and reliable statistical methodologies for developing biosimilars. Some statistical methods have been proposed to assess …

    uthsc Repository record for Novel Bayesian Adaptive Clinical Trial Designs In Early Phases (opens in a new tab)

  7. ELUCIDATION OF THE IMPACT OF N-GLYCAN STRUCTURE ON PHYSICAL STABILITY AND LOCAL FLEXIBILITY OF WELL-DEFINED IgG1-Fc GLYCOFORMS FROM A PHARMACEUTICAL DEVELOPMENT PERSPECTIVE

    … effective development. In comparability and biosimilarity exercises, analytical characterization tools serve as the foundation for establishing similarity between pre change versus post change products and biosimilar versus innovator product. Hence, better tools are needed for drawing …

    ku Repository record for ELUCIDATION OF THE IMPACT OF N-GLYCAN STRUCTURE ON PHYSICAL STABILITY AND LOCAL FLEXIBILITY OF WELL-DEFINED IgG1-Fc GLYCOFORMS FROM A PHARMACEUTICAL DEVELOPMENT PERSPECTIVE (opens in a new tab)

  8. Comparative Effect of Herceptin and Its Biosimilar: Transcriptomic and Proteomic Insights from HER2-Positive Cancer Cell Lines

    … of the originator product that must demonstrate biosimilarity for regulatory approval. This is a very difficult task. Antibodies are large molecules that undergo extensive post-translational modifications (PTMs), which affect their potency, stability, binding affinity, and immunogenicity. Batches …

    waterloo Repository record for Comparative Effect of Herceptin and Its Biosimilar: Transcriptomic and Proteomic Insights from HER2-Positive Cancer Cell Lines (opens in a new tab)

  9. Statistical considerations of noninferiority, bioequivalence and equivalence testing in biosimilars studies

    … (BE) and Equivalence in demonstrating biosimilarity. For NI, one of the key requirements is constancy assumption, that is, the effect of reference treatment is the same in current NI trials as in historical superiority trials. However if a covariate interacts with the treatment arms, …

    bu Repository record for Statistical considerations of noninferiority, bioequivalence and equivalence testing in biosimilars studies (opens in a new tab)

  10. Comparative Evaluation of Well-Defined IgG1 Fc Glycoforms as a Model System for Biosimilar Comparability Analysis

    … to the reference product. The first step in biosimilarity assessment is to establish structural similarity by extensive characterization using several analytical techniques. Therefore, analytical tools play a vital role in demonstrating structural similarity as well as process development of …

    ku Repository record for Comparative Evaluation of Well-Defined IgG1 Fc Glycoforms as a Model System for Biosimilar Comparability Analysis (opens in a new tab)

  11. Tailoring Recombinant Protein Quality by Rational Media Design

    … with respect to the specifications for biosimilarity and selection following a hierarchical order of decisions using a decision tree. The method resulted in a substantial improvement of the targeted glycosylation profile in only two experimental rounds. Subsequent development stages, …

    wurz-thes Repository record for Tailoring Recombinant Protein Quality by Rational Media Design (opens in a new tab)